Recurrent hepatitis B (HB) following orthotopic liver transplantation (OLT) for chronic disease is common. However, an unpredictable minority of patients follow a recurrence-free course. Clinical, virologic, and pathologic data from patients surviving longer than 60 days (n=24) with pathologically confirmed nonrecurrence of HB following OLT for chronic HB were reviewed to identify factors associated with non-recurrence of HB. Nine of 24 patients had no histologic and immunohistologic evidence of recurrent HB. In addition to pre-OLT hepatitis B e antigen (HBeAg) negativity, coexisting delta and anti-HB therapy/prophylaxis, other acquired viral infections and their therapy, and severe acute rejection due to noncompliance were considered the possible protective factors against HB recurrence in these 9 patients. Histologic and, particularly immunopathologic, evaluation of liver biopsies must be utilized in definitively diagnosing recurrence of HB.
1. Lake JR. Should liver transplantation be performed for patients with chronic hepatitis B?Yes! Liver Transplant Surg1:260-265, 1995
2.
2. Todo S, Demetris AJ, VanThiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology13:619-626, 1991
3.
3. O'Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, Tan KC, Portmann B, Alexander GJ, Williams R. Hepatitis B virus re-infection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol14:104-111, 1992
4.
4. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H, et al. Liver transplantation in European patients with hepatitis B surface antigen. N Engl J Med329:1842-1847, 1993
5.
5. Lake JR, Wright TL. Liver transplantation for patients with hepatitis B: What have we learned from our results?Hepatology13:796-799, 1991
6.
6. Clavien PA, Camargo CA Jr, Croxford R, Langer B, Levy GA, Greig PD. Definition and classification of negative outcomes in solid organ transplantation. Ann Surg220:109-120, 1994
7.
7. Huang EJ, Wright TL, Lake JR, Combs C, Ferrel LD. Hepatitis B and C coinfection and persistent hepatitis B infections: Clinical outcome and liver pathology after transplantation. Hepatology23:396-404, 1996
8.
8. Boker KHW, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, Oldhaver K, Bode U, Picklmayr R, Manns MP. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology25:203-210, 1997
9.
9. Dickson RC, Caldwell SH, Ishitani MB, Lau JRN, Driscoll CJ, Stevenson WC, McCullough CS, Pruett TL. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation61:701-705, 1996
10.
10. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, Fennessy S, Roberts JP, Ascher NL, Greenberg HB. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology103:317-322, 1992
11.
11. Berg T, Naumann U, Fukumoto T, Bechstein WO, Neuhaus P, Lobeck H, Hohne M, Schreier E, Hopf U. GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantation. Transplantation62:711-714, 1996
12.
12. Colantoni A, DeMaria N, Fagiuli S, VanThiel DH. Liver transplantation in virus-induced chronic liver disease. Baillieres Clin Gastroenterol10:375-388, 1996
13.
13. Pons JA. Role of liver transplantation in viral hepatitis. Review. J Hepatol22(Suppl 1):146-153, 1995
14.
14. Slapak GI, Saxena R, Portmann B, Gane E, Devlin J, Calne SR, Williams R. Graft and systemic disease in long-term survivors of liver transplantation. Hepatology25:195-202, 1997
15.
15. Smedile A, Rizzetto M. Orthotopic liver transplantation for chronic viral hepatitis: An overview. Int J Clin Lab Res22:211-215, 1992
16.
16. Angus PW. Review: Hepatitis B and liver transplantation. J Gastroenterol Hepatol12:217-223, 1997
17.
17. Yoshida EM. Hepatitis B infection and liver transplantation. Can J Gastroenterol11:562-568, 1997
18.
18. Hemming AW, Cattral MS, Greig PD, Philosophe B, Superina RA, Lilly LB, Levy G. The University of Toronto liver transplant program. Clin Transpl177-185, 1996
19.
19. Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, Pruett T, Terrault N, Roberts J, Ascher N, Wright T, Lake J. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft. Transplantation64:410-414, 1997
20.
20. Wang P, Chaudry I. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol270:R927-R938, 1996
21.
21. Wang P, Zheng F, Chaudry IH. Mechanism of hepatocellular dysfunction during early sepsis. Arch Surg132:364-370, 1997
22.
22. Anand N, Loda M, Gordon F, Lewis D, Khettry U. Recurrent hepatitis B (HB), hepatitis C (HC), and combined hepatitis B & C (HB&C) in liver allografts. Mod Pathol11:150A-150A, 1998
23.
23. Singh N, Gayowski T, Wannstedt CF, Wagener MM, Marino IR. Pretransplant Famcyclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation. Transplantation63:1415-1419, 1997
24.
24. McCaughan G, Angus P, Bowden S, Shaw T, Breschkin A, Sheil R, Locarnini S. Retransplantation for precore mutant-related chronic hepatitis B infection: Prolonged survival in a patient receiving sequential Gancyclovir/Famcyclovir therapy. Liver Transpl Surg2:472-474, 1996
25.
25. Gish RG, Lau JYN, Brooks L, Fang JWS, Steady SL, Imperial JC, Garcia-Kennedy R, Esquivel CO, Keeffe EB. Gancyclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology23:1-7, 1996
26.
26. Grellier L, Mutimer D, Ahmed M, Brown D, Burroughs AK, Rolles K. McMaster P, Beranek P, Kennedy F, Kibbler H, McPhillips P, Elias E, Dusheiko G. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet348:1212-1215, 1996
27.
27. Efficacy of Lamivudine in controlling hepatitis B virus recurrence after liver transplantation. Transplantation65:1615-1621, 1998
28.
28. Ben-Ari Z, Shmueli D, Mor E, Shapira Z, Tur-Kaspa R. Beneficial effect of Lamivudine in recurrent hepatitis B after liver transplantation. Transplantation63:393-396, 1997
29.
29. Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology24:1327-1333, 1996
30.
30. Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, Goss JA, Schmidt P, Pakrasi A, Artinian L, Murray NGB, Imagawa DK, Holt C, Goldstein LI, Stribling R, Busuttil RW. Prophylaxis against hepatitis B recurrence following liver tansplantation using combination Lamivudine and hepatitis B immune globulin. Hepatology28:585-589, 1998
31.
31. Tchervenkov JI, Tector AJ, Barkun JS, Sherker A, Forbes CD, Elias N, Cantarovich M, Cleland P, Metrakos P, Meakins JL. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant. Ann Surg226:356-365, 1997
32.
32. McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC, Caldwell SH, Pruett TL. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation61:1358-1364, 1996
